NAD+ Research Overview
NAD⁺ (nicotinamide adenine dinucleotide) is a redox cofactor and a substrate for NAD-consuming enzymes. It is not a peptide. A laboratory can study NAD⁺ in electron-transfer chemistry, sirtuin reactions, PARP-dependent ADP-ribosylation or CD38-related metabolism, but these are different experiments. Changes in an NAD measurement cannot automatically be translated into a general statement about cellular energy, ageing or human benefit.
Research Use Only: This article concerns biochemical research and the documentation of laboratory materials. Core Research does not supply NAD⁺ for human or veterinary administration, and this guide gives no such instructions.
Why NAD⁺ and NADH must be interpreted together
In dehydrogenase reactions, NAD⁺ accepts reducing equivalents and is converted into NADH. NADH can subsequently participate in other redox reactions. The relative amounts of the oxidised and reduced forms, the location of the reaction and the enzyme system can all be necessary to understand what is being measured.
A report that a total sample contains more NAD⁺ does not itself establish a higher ATP production rate. It may reflect altered synthesis, consumption, redox balance, extraction efficiency or pool size. The correct question is which analyte, compartment and condition the assay actually measured.
NAD⁺ also disappears through enzyme-catalysed consumption
Sirtuins use NAD⁺ in deacylation-related reactions; PARP-family enzymes use it during ADP-ribosylation; and CD38-family enzymes contribute to NADase and metabolite-signalling pathways. In these cases NAD⁺ is consumed, rather than merely cycling reversibly between NAD⁺ and NADH. Rajman, Chwalek and Sinclair survey how redox and consumption pathways connect without being identical.
An assay of one enzyme family should include the substrate and reaction conditions relevant to that enzyme, not imply that every pathway changes when the bulk NAD pool moves. If activity changes, distinguish the measured reaction from an inferred downstream organism-level effect.
| Study question | Direct measurement required | Common interpretation error |
|---|---|---|
| Redox cofactor chemistry | NAD⁺/NADH and relevant dehydrogenase conditions | Calling total NAD⁺ a direct ATP readout |
| Sirtuin activity | Substrate turnover, NAD⁺ dependence and reaction product | Assuming changes in NAD⁺ automatically establish all sirtuin activity |
| PARP pathways | ADP-ribosylation and NAD consumption in the experimental model | Treating every PARP response as a beneficial outcome |
| CD38/NADase | Substrate loss and defined metabolites | Interpreting a cofactor measurement as direct receptor evidence |
| Subcellular NAD⁺ | A compartment-appropriate assay or sensor | Assuming a whole-cell measurement describes all organelles |
Why intracellular compartmentation changes the evidence
NAD-related reactions occur in the nucleus, cytosol and mitochondria, where availability and the enzymes acting on the pool can differ. Cambronne and colleagues (2016) described a genetically encoded fluorescent sensor to examine free NAD⁺ in specific compartments. Their approach showed that local NAD⁺ availability could be considered in relation to the kinetics of enzymes operating in those cellular regions, and that the sources maintaining mitochondrial NAD⁺ were not identical across every cell context.
This is a strong reason to distinguish total sample concentration from local free NAD⁺ concentration. Fractionation, sensor calibration, extraction losses and interference can affect what the analyst sees. A mitochondria-associated response cannot be attributed automatically to a change in the entire cellular NAD pool.
An additional human-cell study of engineered redistribution of NAD⁺ between compartments observed major metabolic effects that were not simply more respiration when mitochondrial NAD⁺ increased (subcellular distribution study). The model was deliberately engineered, and it is not evidence that a commercial NAD⁺ preparation produces the same effects in vivo.
NAD⁺, NADP⁺ and common precursors are different research materials
The NAD⁺/NADH pair is different from NADP⁺/NADPH, which participates in other redox systems, and different again from molecules used in NAD salvage or precursor pathways. NMN and nicotinamide riboside are chemically distinct precursors, not synonyms for NAD⁺. A paper about a precursor intervention measures the properties of that intervention; it does not directly establish the behaviour or stability of externally supplied NAD⁺ in a laboratory assay.
Strømland and colleagues discuss the balance of NAD⁺ biosynthesis and consumption in metabolic research. That review is a secondary synthesis, not primary evidence that the current catalogue material changes an ageing or clinical endpoint.
How should NAD⁺ assays be designed and interpreted?
Define the question before deciding which analytes to measure. Redox work may require paired NAD⁺/NADH results; enzyme-kinetics work requires a properly characterised substrate; and compartmental work requires an approach appropriate to the cellular location. The pH, extraction conditions, time from sampling to measurement and handling of oxidised/reduced forms must be suitable for the exact method.
A useful reporting checklist is:
- Chemical identity: NAD⁺, NADH, another cofactor, precursor or metabolite?
- Sample: cell extract, isolated organelle, purified enzyme or reference preparation?
- Assay: spectrophotometric, enzymatic cycling, chromatography, mass spectrometry or a calibrated sensor?
- Outcome: concentration, redox ratio, turnover or functional readout?
- Controls: extraction recovery, background, interference and appropriate comparisons?
- Boundary: does this result describe an assay component, a cellular mechanism or a whole-organism finding?
This is a laboratory decision framework, not a protocol prescribing a universal concentration, preparation temperature or storage period.
What can a Core Research batch document establish?
A supplied product’s exact chemical form, declared amount and applicable lot-specific method/result belong to its actual documentation. Analytical identity and chromatographic profile are separate from quantitative content, microbiological quality, sterility or post-preparation stability. A general NAD⁺ paper cannot substitute for a material-specific batch record.
The CoA-reading guide explains how to separate specification from result, and Batch Documentation is the route for questions about a named catalogue product or received lot. Although that guidance frequently illustrates peptides, the evidence principle also applies to this non-peptide cofactor.
NAD⁺ catalogue formats and related entities
Core Research lists NAD⁺ 1000mg and NAD⁺ Refill 1000mg. The refill is a different finished presentation, and cofactor-level biochemical literature does not establish its cartridge compatibility or finished-form stability. The Metabolic & NAD⁺ category also includes compounds such as MOTS-c and SS-31; they do not share NAD⁺’s chemical identity or necessarily its assay methods.
Research references
- Rajman L, Chwalek K, Sinclair DA. NAD⁺ metabolism: bioenergetics, signaling and manipulation. Cell Metabolism, 2018. PMID: 27374990. Review/background.
- Cambronne XA et al. Biosensor reveals multiple sources for mitochondrial NAD⁺. Science, 2016. DOI: 10.1126/science.aad5168. Original compartment-targeted sensor study.
- Subcellular distribution of NAD⁺ between cytosol and mitochondria determines the metabolic profile of human cells. 2015. PMID: 26432643. Engineered human-cell model, not an intervention trial.
- Strømland Ø et al. The balance between NAD⁺ biosynthesis and consumption in ageing. 2021. PMID: 34509469. Secondary synthesis of pathways.